10.60Open13.89Pre Close1 Volume1 Open Interest83.00Strike Price1.06KTurnover5092.69%IV0.59%PremiumNov 22, 2024Expiry Date10.17Intrinsic Value100Multiplier0DDays to Expiry0.43Extrinsic Value100Contract SizeAmericanOptions Type-0.9054Delta0.0239Gamma6.90Leverage Ratio-439.2893Theta0.0000Rho-6.25Eff Leverage0.0002Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet